Search Results 1901-1910 of 17401 for magnesiummagnesium

1. A Study to Evaluate a Standard-dose and High- dose Regimen of Encorafenib + Binimetinib in Patients with BRAFV600-mutant Melanoma Brain Metastasis - Mayo Clinic

   All patients (Safety Lead-In and Phase 2): If receiving concomitant corticosteroids must be on a stable or decreasing dose (up to a total daily dose of 4 mg ...

2. Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer - Mayo Clinic

   Giving the drugs in different combinations may kill more breast cancer cells. Giving combination chemotherapy after surgery may kill any tumor cells that remain ...

3. Azacitidine and Sonidegib in Treating Patients With Myeloid Malignancies - Mayo Clinic

   Total bilirubin ≤ 1.5 mg/dL (except Gilbert's syndrome or known hemolysis or leukemic infiltration); Aspartate aminotransferase (AST) (serum glutamic ...

4. Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma - Mayo Clinic

   Ipilimumab (3 mg/kg every 3 weeks; up to four doses) began week 1 in the ipilimumab alone arm and week 6 in the combination arm. The primary end point was ...

5. A Phase 2, Multi-center, Open-label Study to Evaluate the Efficacy and Safety of Luspatercept (ACE-536) in Subjects with Myeloproliferative Neoplasm-Associated Myelofibrosis and Anemia with and without Red Blood Cell-Transfusion Dependence - Mayo Clinic

   ... mg prednisone for the 28 days immediately up to enrollment. Cohort 1 and 2 only: Subjects treated with JAK2 inhibitors ≤ 112 days immediately up to the ...

6. Dr. Todd Nippoldt Archives - Mayo Clinic News Network

   happens chiefly if you take thyroid hormone replacement and calcium supplements at or near the same time. Other supplements, including those containing ...

7. A Study to Evaluate Preoperative Oral Microbiota-Based Investigational New Drug to Target Immune Response in Patients with Operable Stage I-III Breast Cancer - Mayo Clinic

   Immunocompromised patients including patients known to be HIV positive or those on chronic steroids > 20 mg prednisone a day or prednisone-equivalent. Note ...

8. The Effect of Glutamine on Intestinal Permeability and Symptoms in Patients with Functional Dyspepsia in a Randomized, Placebo-Controlled Trial - Mayo Clinic

   Of note, patients taking PPIs will be given the opportunity to discontinue their PPI in favor of famotidine 20 mg daily for 2 weeks before enrollment.

9. Ergoloid mesylates (oral route, sublingual route) - Side effects & dosage - Mayo Clinic

   For oral dosage forms (capsules, tablets, sublingual tablets, or oral solution):. Adults: 1 to 2 milligrams (mg) three times a day. Storage. Store the ...

10. Study Of The Bria-IMT Regimen And CPI Vs Physicians' Choice In Advanced Metastatic Breast Cancer. (BRIA-ABC) - Mayo Clinic

    Have a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (doses exceeding 10 mg daily of prednisone equivalent) or any other ...